3D Printing of Bioactive Structures for Engineering Artificial Tissues

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Biological and Bio- Materials".

Deadline for manuscript submissions: closed (1 January 2022) | Viewed by 4030

Special Issue Editor


E-Mail Website
Guest Editor
Department of Mechanical Engineering, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
Interests: 3D printing; biomaterials; tissue engineering; ceramics; flexible electronics; cellular and molecular bioengineering

Special Issue Information

Dear Colleagues,

Tissue and organ printing are essential pieces in a larger scale biological puzzle that could be the key to the realization of a fully functional yet artificial body. At their core, tissue and organ printing technologies involve additive robotic biofabrication of functional three-dimensional tissue and organ constructs, in a layer-by-layer manner. Hence, in this Special Issue, we are inviting research (full papers, communications, and review articles) covering advances and novel methodologies in bioprinting of tissues and organs, including: 3D printing of biopolymeric/bioceramic/biocomposite scaffolds, the correlation between printing parameters and subsequent properties of the scaffolds, corresponding cell studies on the mentioned scaffolds, and lastly novel 3D printing technologies for fabrication of scaffolds with intricate structures.

Dr. Mehdi Mehrali
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • 3D printing
  • additive manufacturing
  • bioprinting
  • biomaterials
  • tissue engineering
  • regenerative medicine
  • bioink
  • hydrogels
  • bioceramics

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 3273 KiB  
Review
The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability
by Nabeel M. Althabhawi and Zinatul Ashiqin Zainol
Biomolecules 2022, 12(1), 124; https://doi.org/10.3390/biom12010124 - 12 Jan 2022
Cited by 8 | Viewed by 3309
Abstract
A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of these [...] Read more.
A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of these technologies could be hindered, unless there is adequate and effective protection for related applications. In this article, the authors examine the patent eligibility of 3D bioprinting technologies. This issue raises concern given that existing patent systems are generally averse to nature-derived inventions and many of them exclude products of nature or discoveries from patentability. This qualitative study analyses the current patent systems in key jurisdictions, particularly, the U.S. and the EU, and their applicability, as well as effectiveness, in the context of 3D bioprinting. The study argues that the main reason for the apathy of existing patent systems towards bio-inventions is that they were designed to deal with mechanical inventions. It suggests an innovation framework that encompasses both mechanical and biological inventions to cater adequately to emerging technologies. Full article
Show Figures

Figure 1

Back to TopTop